SMAD3 and liver disorder: Although the complete upstream signaling pathways of NOXs remain unknown, TGFβ1/SMAD signaling pathway, a well‐known regulator in the progression of liver diseases,30, 31 has been shown to regulate NOX4/ROS pathway in a SMAD3‐dependent manner.32